nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.122	0.193	CbGbCtD
Rimonabant—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.102	0.161	CbGbCtD
Rimonabant—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0978	0.154	CbGbCtD
Rimonabant—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0641	0.101	CbGbCtD
Rimonabant—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0596	0.0939	CbGbCtD
Rimonabant—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0478	0.0754	CbGbCtD
Rimonabant—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0439	0.0692	CbGbCtD
Rimonabant—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0273	0.0431	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0269	0.0424	CbGbCtD
Rimonabant—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0251	0.0395	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0171	0.0269	CbGbCtD
Rimonabant—CNR1—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00459	0.198	CbGpPWpGaD
Rimonabant—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000849	0.00248	CcSEcCtD
Rimonabant—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000848	0.00248	CcSEcCtD
Rimonabant—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000846	0.00247	CcSEcCtD
Rimonabant—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000846	0.00247	CcSEcCtD
Rimonabant—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000841	0.00246	CcSEcCtD
Rimonabant—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000835	0.00244	CcSEcCtD
Rimonabant—CNR1—N-cadherin signaling events—PTPN11—peripheral nervous system neoplasm	0.000829	0.0357	CbGpPWpGaD
Rimonabant—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000825	0.00241	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00082	0.00239	CcSEcCtD
Rimonabant—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.00239	CcSEcCtD
Rimonabant—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000819	0.00239	CcSEcCtD
Rimonabant—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000819	0.00239	CcSEcCtD
Rimonabant—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000819	0.00239	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000813	0.00237	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000813	0.00237	CcSEcCtD
Rimonabant—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000812	0.00237	CcSEcCtD
Rimonabant—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000812	0.00237	CcSEcCtD
Rimonabant—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.00081	0.00236	CcSEcCtD
Rimonabant—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000808	0.00236	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000803	0.00234	CcSEcCtD
Rimonabant—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000801	0.00234	CcSEcCtD
Rimonabant—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00078	0.00228	CcSEcCtD
Rimonabant—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000776	0.00227	CcSEcCtD
Rimonabant—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000771	0.00225	CcSEcCtD
Rimonabant—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00077	0.00225	CcSEcCtD
Rimonabant—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00077	0.00225	CcSEcCtD
Rimonabant—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.00223	CcSEcCtD
Rimonabant—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000758	0.00221	CcSEcCtD
Rimonabant—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000751	0.00219	CcSEcCtD
Rimonabant—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000745	0.00218	CcSEcCtD
Rimonabant—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000745	0.00217	CcSEcCtD
Rimonabant—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000745	0.00217	CcSEcCtD
Rimonabant—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000742	0.00217	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.00216	CcSEcCtD
Rimonabant—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000734	0.00214	CcSEcCtD
Rimonabant—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00073	0.00213	CcSEcCtD
Rimonabant—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000728	0.00213	CcSEcCtD
Rimonabant—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000716	0.00209	CcSEcCtD
Rimonabant—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000712	0.00208	CcSEcCtD
Rimonabant—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000709	0.00207	CcSEcCtD
Rimonabant—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000707	0.00206	CcSEcCtD
Rimonabant—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.0007	0.00204	CcSEcCtD
Rimonabant—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000698	0.00204	CcSEcCtD
Rimonabant—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.00202	CcSEcCtD
Rimonabant—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00069	0.00201	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000686	0.0295	CbGpPWpGaD
Rimonabant—Infection—Vincristine—peripheral nervous system neoplasm	0.000683	0.00199	CcSEcCtD
Rimonabant—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000681	0.00199	CcSEcCtD
Rimonabant—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00068	0.00199	CcSEcCtD
Rimonabant—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.000679	0.00198	CcSEcCtD
Rimonabant—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000676	0.00197	CcSEcCtD
Rimonabant—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000676	0.00197	CcSEcCtD
Rimonabant—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000674	0.00197	CcSEcCtD
Rimonabant—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.000673	0.00197	CcSEcCtD
Rimonabant—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000672	0.00196	CcSEcCtD
Rimonabant—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000669	0.00195	CcSEcCtD
Rimonabant—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000667	0.00195	CcSEcCtD
Rimonabant—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000666	0.00195	CcSEcCtD
Rimonabant—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000666	0.00195	CcSEcCtD
Rimonabant—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000665	0.00194	CcSEcCtD
Rimonabant—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000664	0.00194	CcSEcCtD
Rimonabant—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000658	0.00192	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000656	0.00192	CcSEcCtD
Rimonabant—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000656	0.00191	CcSEcCtD
Rimonabant—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000651	0.0019	CcSEcCtD
Rimonabant—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00065	0.0019	CcSEcCtD
Rimonabant—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000648	0.00189	CcSEcCtD
Rimonabant—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000646	0.00188	CcSEcCtD
Rimonabant—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.00188	CcSEcCtD
Rimonabant—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000644	0.00188	CcSEcCtD
Rimonabant—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000644	0.00188	CcSEcCtD
Rimonabant—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00187	CcSEcCtD
Rimonabant—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000636	0.00186	CcSEcCtD
Rimonabant—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000635	0.0273	CbGpPWpGaD
Rimonabant—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000632	0.00185	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00063	0.00184	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000629	0.00184	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000629	0.00183	CcSEcCtD
Rimonabant—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000628	0.00183	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00182	CcSEcCtD
Rimonabant—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000623	0.00182	CcSEcCtD
Rimonabant—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000623	0.00182	CcSEcCtD
Rimonabant—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000622	0.00182	CcSEcCtD
Rimonabant—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.00181	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000619	0.0266	CbGpPWpGaD
Rimonabant—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000618	0.0018	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000616	0.0018	CcSEcCtD
Rimonabant—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000615	0.0018	CcSEcCtD
Rimonabant—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000609	0.00178	CcSEcCtD
Rimonabant—Infection—Cisplatin—peripheral nervous system neoplasm	0.000604	0.00176	CcSEcCtD
Rimonabant—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000604	0.00176	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.00176	CcSEcCtD
Rimonabant—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000602	0.00176	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.0006	0.00175	CcSEcCtD
Rimonabant—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000599	0.00175	CcSEcCtD
Rimonabant—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000599	0.00175	CcSEcCtD
Rimonabant—Rash—Topotecan—peripheral nervous system neoplasm	0.000599	0.00175	CcSEcCtD
Rimonabant—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000598	0.00175	CcSEcCtD
Rimonabant—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000598	0.00175	CcSEcCtD
Rimonabant—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000596	0.00174	CcSEcCtD
Rimonabant—Headache—Topotecan—peripheral nervous system neoplasm	0.000595	0.00174	CcSEcCtD
Rimonabant—Rash—Tretinoin—peripheral nervous system neoplasm	0.000594	0.00173	CcSEcCtD
Rimonabant—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000594	0.00173	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000594	0.00173	CcSEcCtD
Rimonabant—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000593	0.00173	CcSEcCtD
Rimonabant—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000593	0.00173	CcSEcCtD
Rimonabant—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000593	0.00173	CcSEcCtD
Rimonabant—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000591	0.00173	CcSEcCtD
Rimonabant—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000591	0.00173	CcSEcCtD
Rimonabant—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000591	0.00172	CcSEcCtD
Rimonabant—Headache—Tretinoin—peripheral nervous system neoplasm	0.00059	0.00172	CcSEcCtD
Rimonabant—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00059	0.00172	CcSEcCtD
Rimonabant—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000588	0.00172	CcSEcCtD
Rimonabant—Rash—Melphalan—peripheral nervous system neoplasm	0.000586	0.00171	CcSEcCtD
Rimonabant—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000586	0.00171	CcSEcCtD
Rimonabant—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000584	0.0017	CcSEcCtD
Rimonabant—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00058	0.00169	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000577	0.00169	CcSEcCtD
Rimonabant—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.00165	CcSEcCtD
Rimonabant—Nausea—Topotecan—peripheral nervous system neoplasm	0.000564	0.00165	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000562	0.00164	CcSEcCtD
Rimonabant—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000559	0.00163	CcSEcCtD
Rimonabant—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000559	0.00163	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.00163	CcSEcCtD
Rimonabant—Infection—Etoposide—peripheral nervous system neoplasm	0.000554	0.00162	CcSEcCtD
Rimonabant—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000552	0.00161	CcSEcCtD
Rimonabant—Nausea—Melphalan—peripheral nervous system neoplasm	0.000552	0.00161	CcSEcCtD
Rimonabant—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000549	0.0016	CcSEcCtD
Rimonabant—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000546	0.00159	CcSEcCtD
Rimonabant—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000544	0.00159	CcSEcCtD
Rimonabant—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000541	0.00158	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000539	0.00157	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000538	0.0231	CbGpPWpGaD
Rimonabant—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000531	0.00155	CcSEcCtD
Rimonabant—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000529	0.00154	CcSEcCtD
Rimonabant—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000527	0.00154	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000526	0.0226	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000525	0.00153	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000522	0.0225	CbGpPWpGaD
Rimonabant—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.0015	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00149	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.00148	CcSEcCtD
Rimonabant—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.00147	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000501	0.0215	CbGpPWpGaD
Rimonabant—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.0005	0.00146	CcSEcCtD
Rimonabant—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000493	0.00144	CcSEcCtD
Rimonabant—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00143	CcSEcCtD
Rimonabant—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00143	CcSEcCtD
Rimonabant—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000489	0.00143	CcSEcCtD
Rimonabant—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000488	0.00143	CcSEcCtD
Rimonabant—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000485	0.00142	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000484	0.00141	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000481	0.0014	CcSEcCtD
Rimonabant—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00048	0.0014	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.00138	CcSEcCtD
Rimonabant—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.00138	CcSEcCtD
Rimonabant—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000471	0.00137	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000459	0.00134	CcSEcCtD
Rimonabant—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000457	0.00133	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000456	0.00133	CcSEcCtD
Rimonabant—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000455	0.00133	CcSEcCtD
Rimonabant—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00132	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00132	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.00132	CcSEcCtD
Rimonabant—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00131	CcSEcCtD
Rimonabant—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00131	CcSEcCtD
Rimonabant—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000447	0.00131	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00044	0.00129	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000437	0.00128	CcSEcCtD
Rimonabant—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000437	0.00128	CcSEcCtD
Rimonabant—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000436	0.00127	CcSEcCtD
Rimonabant—Rash—Vincristine—peripheral nervous system neoplasm	0.000434	0.00127	CcSEcCtD
Rimonabant—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000433	0.00126	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00126	CcSEcCtD
Rimonabant—Headache—Vincristine—peripheral nervous system neoplasm	0.000431	0.00126	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000429	0.0184	CbGpPWpGaD
Rimonabant—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00124	CcSEcCtD
Rimonabant—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00124	CcSEcCtD
Rimonabant—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000416	0.00121	CcSEcCtD
Rimonabant—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000415	0.0179	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00041	0.0176	CbGpPWpGaD
Rimonabant—Nausea—Vincristine—peripheral nervous system neoplasm	0.000409	0.00119	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.00118	CcSEcCtD
Rimonabant—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0004	0.00117	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00117	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000399	0.00116	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000396	0.00116	CcSEcCtD
Rimonabant—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000394	0.00115	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000393	0.0169	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000393	0.0169	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000388	0.0167	CbGpPWpGaD
Rimonabant—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00113	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000385	0.00112	CcSEcCtD
Rimonabant—Rash—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00112	CcSEcCtD
Rimonabant—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00112	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000383	0.00112	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000381	0.00111	CcSEcCtD
Rimonabant—Tension—Epirubicin—peripheral nervous system neoplasm	0.000376	0.0011	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000372	0.00109	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.00108	CcSEcCtD
Rimonabant—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000368	0.00108	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00107	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00107	CcSEcCtD
Rimonabant—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000361	0.00105	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.00104	CcSEcCtD
Rimonabant—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000354	0.00103	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.00103	CcSEcCtD
Rimonabant—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000353	0.0152	CbGpPWpGaD
Rimonabant—Rash—Etoposide—peripheral nervous system neoplasm	0.000351	0.00103	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000351	0.00102	CcSEcCtD
Rimonabant—Headache—Etoposide—peripheral nervous system neoplasm	0.000349	0.00102	CcSEcCtD
Rimonabant—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.00101	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.001	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000994	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000339	0.0146	CbGpPWpGaD
Rimonabant—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000968	CcSEcCtD
Rimonabant—Nausea—Etoposide—peripheral nervous system neoplasm	0.000331	0.000966	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000948	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000945	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000319	0.00093	CcSEcCtD
Rimonabant—Infection—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000906	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000308	0.0133	CbGpPWpGaD
Rimonabant—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000896	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000894	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000304	0.0131	CbGpPWpGaD
Rimonabant—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000886	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000881	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000877	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000874	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000869	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000295	0.0127	CbGpPWpGaD
Rimonabant—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000861	CcSEcCtD
Rimonabant—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000838	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000827	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000825	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000819	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000819	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000816	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000804	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000273	0.0118	CbGpPWpGaD
Rimonabant—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000793	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000787	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000786	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000268	0.0115	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000266	0.0114	CbGpPWpGaD
Rimonabant—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000763	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000758	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000257	0.0111	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000746	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000733	CcSEcCtD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00025	0.0108	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000728	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000727	CcSEcCtD
Rimonabant—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000721	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000242	0.0104	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.00069	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000235	0.0101	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000232	0.00996	CbGpPWpGaD
Rimonabant—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000667	CcSEcCtD
Rimonabant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000227	0.00978	CbGpPWpGaD
Rimonabant—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000654	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000224	0.00962	CbGpPWpGaD
Rimonabant—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000645	CcSEcCtD
Rimonabant—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000624	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00021	0.00905	CbGpPWpGaD
Rimonabant—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000208	0.00894	CbGpPWpGaD
Rimonabant—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000605	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000603	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000205	0.00883	CbGpPWpGaD
Rimonabant—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000597	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000203	0.00874	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000202	0.00867	CbGpPWpGaD
Rimonabant—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00058	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000198	0.00852	CbGpPWpGaD
Rimonabant—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000577	CcSEcCtD
Rimonabant—Rash—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000575	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000574	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000196	0.00844	CbGpPWpGaD
Rimonabant—Headache—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000571	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000558	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000187	0.00806	CbGpPWpGaD
Rimonabant—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000542	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000184	0.00792	CbGpPWpGaD
Rimonabant—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000536	CcSEcCtD
Rimonabant—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000532	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000531	CcSEcCtD
Rimonabant—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000529	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000175	0.00755	CbGpPWpGaD
Rimonabant—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000501	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000169	0.00728	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000161	0.00693	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000159	0.00686	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000158	0.00681	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000152	0.00653	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000147	0.00633	CbGpPWpGaD
Rimonabant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000137	0.0059	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000133	0.0057	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000131	0.00562	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000124	0.00534	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00012	0.00518	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.00012	0.00517	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00012	0.00516	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000119	0.00512	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000116	0.00499	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000111	0.00476	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000106	0.00457	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000105	0.00453	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000104	0.00448	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.45e-05	0.00406	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.41e-05	0.00405	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.1e-05	0.00391	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.69e-05	0.00374	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.32e-05	0.00358	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.26e-05	0.00355	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.46e-05	0.00321	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.32e-05	0.00315	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.11e-05	0.00306	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.78e-05	0.00292	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.53e-05	0.00281	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.37e-05	0.00274	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.22e-05	0.00268	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.74e-05	0.00247	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	5.66e-05	0.00243	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.58e-05	0.0024	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.32e-05	0.00229	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	5.27e-05	0.00227	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.96e-05	0.00213	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.92e-05	0.00211	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.88e-05	0.0021	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.4e-05	0.00189	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.32e-05	0.00186	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.2e-05	0.00181	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	4.14e-05	0.00178	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.45e-05	0.00149	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.42e-05	0.00147	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.39e-05	0.00146	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.35e-05	0.00144	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.32e-05	0.00143	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.24e-05	0.00139	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.22e-05	0.00138	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.13e-05	0.00135	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.1e-05	0.00133	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.84e-05	0.00122	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.84e-05	0.00122	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.76e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.68e-05	0.00115	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.6e-05	0.00112	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.53e-05	0.00109	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.46e-05	0.00106	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.43e-05	0.00105	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	2.42e-05	0.00104	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.42e-05	0.00104	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	2.4e-05	0.00103	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.36e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	2.32e-05	0.000999	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	2.3e-05	0.00099	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	2.23e-05	0.000961	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.23e-05	0.000959	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	2.22e-05	0.000953	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.19e-05	0.000942	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.05e-05	0.000883	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.04e-05	0.000877	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.99e-05	0.000855	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.97e-05	0.000846	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.9e-05	0.000818	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.9e-05	0.000817	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.89e-05	0.000814	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.68e-05	0.000722	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.58e-05	0.000681	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.56e-05	0.000671	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.52e-05	0.000653	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.49e-05	0.000642	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.47e-05	0.000631	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.46e-05	0.000629	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.45e-05	0.000626	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000567	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.24e-05	0.000535	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.24e-05	0.000533	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.23e-05	0.000529	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000509	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.17e-05	0.000504	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.17e-05	0.000501	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.16e-05	0.000497	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.05e-05	0.000452	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1e-05	0.000431	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	9.87e-06	0.000425	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	9.59e-06	0.000413	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	9.51e-06	0.000409	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	9.43e-06	0.000406	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	9.34e-06	0.000402	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	9.26e-06	0.000398	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	8.1e-06	0.000349	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	8.06e-06	0.000347	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.91e-06	0.00034	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.73e-06	0.000333	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.62e-06	0.000328	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	6.22e-06	0.000268	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	6.1e-06	0.000263	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	2.57e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.55e-06	0.00011	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.18e-06	9.36e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.68e-06	7.22e-05	CbGpPWpGaD
